tidal medical technologies
tidal medical technologies
  • Home
  • Healthcare Professionals
  • Investors & Team
  • News
  • Contact
  • More
    • Home
    • Healthcare Professionals
    • Investors & Team
    • News
    • Contact
  • Home
  • Healthcare Professionals
  • Investors & Team
  • News
  • Contact

InSee

InSeeInSeeInSee

The First Smart Monitoring System 

for Incentive Spirometers

Cost of hospital ReadmissioNs due to PNEUMONIA

We all know people who've died from Pneumonia. The most common type, Hospital-Acquired Pneumonia (HAP), is defined as pneumonia that occurs 48 hours or more after hospital admission. Most COVID fatalities were in fact due to covid-induced Pneumonia.  In addition to the human cost, US Healthcare wastes $10 billion a year due to Hospital-Acquired Pneumonia

What is InSee?

Incentive Spirometer is an existing disposable mechanical ventilator used to promote deep breathing to help prevent pneumonia in post-surgical and respiratory patients.
Developed by Tidal Medical Technologies, InSee is a patented smart monitoring system that quantitatively tracks patient usage of an incentive spirometers. Incentive Spirometer is an existing single-patient disposable device used to promote deep breathing to help prevent hospital-acquired pneumonia in post-surgical and respiratory patients.


Use of InSee in conjunction with an incentive spirometer may assist in treating respiratory conditions and improve clinical outcomes by monitoring and encouraging more frequent and consistent usage of the spirometer, without reliance on the presence of the healthcare provider or reliance on the patient’s memory and reporting for use of the spirometer.


The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the use of InSee as an accessory to Vyaire Medical’s AirLife incentive spirometer in patients with COVID-19*.  

Features & benefits

Smart Patient Coaching

Continuous Tidal Volume Monitoring

Quantitative Compliance Tracking

Help promote patient compliance and better outcomes.

Quantitative Compliance Tracking

Continuous Tidal Volume Monitoring

Quantitative Compliance Tracking

Know which patients are at higher risk due to non–compliance for more efficient staff workflow.

Continuous Tidal Volume Monitoring

Continuous Tidal Volume Monitoring

Continuous Tidal Volume Monitoring

Early detection & risk stratification to help promote lower the length of stay & readmissions.

Try insee in your hospital

We're currently preparing to launch our first clinical study and pilot program, in Q2, 2022. If you are interested in participating, please contact us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

* The InSee has neither been cleared nor approved by the FDA, but has been authorized by FDA under a EUA for quantitatively tracking patient usage of Vyaire Medical’s AirLife incentive spirometer as an aid in treatment of respiratory conditions during the COVID-19 pandemic; and  The emergency use of the InSee is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of medical devices during the COVID-19 outbreak.

** https://jamanetwork.com/journals/jamasurgery/fullarticle/2730077

  • Home
  • Healthcare Professionals
  • Investors & Team
  • News

Tidal Medical Technologies

2120 University Ave, Ste 500 Berkeley, CA 94704

Copyright © 2021 tidal medical technologies - All Rights Reserved.